$UATG The loss (depreciation) on those assets are recouped in the long with carryforward/carryback (tax purposes). Which makes us even more attractive for a large company such as Noble Bio to merge with us.
That’s not accurate. Market cap has almost nothing to do with the value of a company especially in the pinks.
What you pay for an asset is absolutely relevant because if it wasn’t there would be hell to pay if you over paid for an asset using shareholders investment/equity. You can dispute its value but read the financials and what they have invested. Their assets are around $35M. The proof is that the banks obviously agree or else they wouldn’t have financed the company or its debt
News 
Market Data 
Discover 
AI
